High dose ifosfamide with mesna uroprotection. 1993

T Cerny
Institut für Medizinische Onkologie, Inselspital, Berne, Switzerland.

UI MeSH Term Description Entries
D007069 Ifosfamide Positional isomer of CYCLOPHOSPHAMIDE which is active as an alkylating agent and an immunosuppressive agent. Isofosfamide,Isophosphamide,Asta Z 4942,Holoxan,Iphosphamide,Iso-Endoxan,NSC-109,724,NSC-109724,Iso Endoxan,NSC 109,724,NSC 109724,NSC109,724,NSC109724
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014570 Urologic Diseases Pathological processes of the URINARY TRACT in both males and females. Urinary Tract Diseases,Urological Diseases,Disease, Urinary Tract,Disease, Urologic,Disease, Urological,Diseases, Urinary Tract,Diseases, Urologic,Diseases, Urological,Urinary Tract Disease,Urologic Disease,Urological Disease
D015080 Mesna A sulfhydryl compound used to prevent urothelial toxicity by inactivating metabolites from ANTINEOPLASTIC AGENTS, such as IFOSFAMIDE or CYCLOPHOSPHAMIDE. 2-Mercaptoethanesulfonate,Coenzyme M,Ethanesulfonic acid, 2-mercapto-, monosodium salt,ASTA-D 7093,MESNA-cell,Mesnex,Mesnum,Mistabron,Mistabronco,Mitexan,Mucofluid,Sodium 2-Mercaptoethanesulphonate,UCB-3983,Uromitexan,Ziken,2 Mercaptoethanesulfonate,2-Mercaptoethanesulphonate, Sodium,ASTA D 7093,ASTAD 7093,MESNA cell,UCB 3983,UCB3983

Related Publications

T Cerny
January 1989, Cancer chemotherapy and pharmacology,
T Cerny
January 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
T Cerny
April 1990, American journal of clinical oncology,
T Cerny
January 1990, Cancer chemotherapy and pharmacology,
T Cerny
January 1989, Cancer chemotherapy and pharmacology,
T Cerny
January 1992, Journal of intravenous nursing : the official publication of the Intravenous Nurses Society,
Copied contents to your clipboard!